1. Home
  2. LNTH vs NIO Comparison

LNTH vs NIO Comparison

Compare LNTH & NIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • NIO
  • Stock Information
  • Founded
  • LNTH 1956
  • NIO 2014
  • Country
  • LNTH United States
  • NIO China
  • Employees
  • LNTH N/A
  • NIO N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • NIO Auto Manufacturing
  • Sector
  • LNTH Health Care
  • NIO Consumer Discretionary
  • Exchange
  • LNTH Nasdaq
  • NIO Nasdaq
  • Market Cap
  • LNTH 7.5B
  • NIO 7.4B
  • IPO Year
  • LNTH 2015
  • NIO 2018
  • Fundamental
  • Price
  • LNTH $78.95
  • NIO $4.13
  • Analyst Decision
  • LNTH Strong Buy
  • NIO Hold
  • Analyst Count
  • LNTH 5
  • NIO 6
  • Target Price
  • LNTH $133.80
  • NIO $5.05
  • AVG Volume (30 Days)
  • LNTH 1.3M
  • NIO 35.5M
  • Earning Date
  • LNTH 05-07-2025
  • NIO 06-05-2025
  • Dividend Yield
  • LNTH N/A
  • NIO N/A
  • EPS Growth
  • LNTH N/A
  • NIO N/A
  • EPS
  • LNTH 3.53
  • NIO N/A
  • Revenue
  • LNTH $1,536,699,000.00
  • NIO $9,005,433,398.00
  • Revenue This Year
  • LNTH $5.81
  • NIO $37.90
  • Revenue Next Year
  • LNTH $12.26
  • NIO $26.13
  • P/E Ratio
  • LNTH $22.69
  • NIO N/A
  • Revenue Growth
  • LNTH 12.53
  • NIO 18.18
  • 52 Week Low
  • LNTH $74.34
  • NIO $3.02
  • 52 Week High
  • LNTH $126.89
  • NIO $7.71
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 27.93
  • NIO 54.77
  • Support Level
  • LNTH $78.61
  • NIO $3.82
  • Resistance Level
  • LNTH $83.60
  • NIO $4.27
  • Average True Range (ATR)
  • LNTH 3.87
  • NIO 0.16
  • MACD
  • LNTH -3.13
  • NIO 0.03
  • Stochastic Oscillator
  • LNTH 1.12
  • NIO 49.19

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About NIO NIO Inc. American depositary shares each representing one ordinary share

Nio is a leading electric vehicle maker, targeting the premium segment. Founded in November 2014, Nio designs, develops, jointly manufactures, and sells premium smart electric vehicles. The company differentiates itself through continuous technological breakthroughs and innovations such as battery swapping and autonomous driving technologies. Nio launched its first model, its ES8 seven-seater electric SUV, in December 2017, and began deliveries in June 2018. Its current model portfolio includes midsize to large sedans and SUVs. It sold around 222,000 EVs in 2024, accounting for about 2% of the China passenger new energy vehicle market.

Share on Social Networks: